Paul, Weiss

Jacob Adlerstein

Deals
2
Latest
Jun 2026

Firm

Often works with

Deals

Deals dated after 30 September 2026 are still being collected.

Columns
Deals Jacob Adlerstein was named on, most recent first
Jun 2026 Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program Sangamo TherapeuticsEli Lilly and CompanyAsset saleLegal adviser to Eli Lilly and Company (acquirer)Completed–Biotech+1Eli Lilly and Company acquisition of Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program
Feb 2026 Substantially all PosiGen assets PosiGenBrookfield Asset ManagementAsset saleLegal adviser to Brookfield Asset Management (acquirer)Completed–RenewablesBrookfield Asset Management acquisition of Substantially all PosiGen assets

Deals where Jacob Adlerstein is named on the firm's deal team, by the firm or the press.

Suggest a correction

A missing deal, a wrong firm, a move between firms, or two different people shown as one. A link to a public source helps.